Parenteral Drugs (India) Ltd - PARENTERAL DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE904D01019
₹ 2.90 (1.75%) icon21 Aug, 2023, 1:45:11 PM
Open
₹ 2.70
Prev. Close
₹ 2.85
Turnover(lac)
₹ 0.00
Day's High
₹ 2.90
Day's Low
₹ 2.70
52 Wk High
₹ 3.30
52 Wk Low
₹ 2.70
Book Value
₹ -290.46
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 8.65
P/E
0.00
EPS
0.00
Div. Yield
0.00

Parenteral Drugs (India) Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 8/21/2023 1:45:11 PM

    ₹ 2.9 0.05 1.75
  • Open
  • ₹ 2.7
  • Prev. Close
  • ₹ 2.85
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 2.9
  • Day's Low
  • ₹ 2.7
  • 52 Week's High
  • ₹ 3.3
  • 52 Week's Low
  • ₹ 2.7
  • Book Value
  • ₹ -290.46
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 8.65
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Parenteral Drugs (India) Ltd Corporate Actions

No Record Found


Parenteral Drugs (India) Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Parenteral Drugs (India) Ltd SHAREHOLDING SNAPSHOT
19 May , 2024 | 01:17 AM

PROMOTER - TOTAL73.29%

Indian: 73.29%

Foreign: 0%

NON-PROMOTER - TOTAL 26.71%

Institutions: 0.01%

Non-Institutions: 26.71%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Parenteral Drugs (India) Ltd FINANCIALS

View Profit & Loss Graph

Parenteral Drugs (India) Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Parenteral Drugs (India) Ltd

  • Manoharlal Gupta
  • Chairman
  • Govind Das Garg
  • Whole-time Director
  • Dharam Pal Khanna
  • Independent Director
  • Dilip Kumar Sinha
  • Independent Director
  • Anil Mittal
  • Non Executive Director
  • Manish Verma
  • Independent Director
  • Vinod Kumar Gupta
  • Managing Director & CFO
  • Deepali Garhewal
  • Independent Director
  • Chhaya Gupta
  • Independent Director

Summary

Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company. In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum. In March 1994, the company was converted into a public limited company. Parenteral Drugs (India) is an India-based pharmaceutical company. The Company manufactures, and markets pharmaceutical products in India, including solid and liquid orals, such as antibiotics and anti-bacterial, anti-ulcerant, analgesics/anti-inflammatory, multivitamins and minerals, anxiolyic , antiprotozoal, anticold, anthelmintic, anti-histaminic, muscle relaxant, cardiac, antidiabetic, cough syrup, appetite enhancer and injections. The Company produces various therapeutic segments of In-Vitro (I V) Fluids, such as electrolytes, antibacterial, energy replenisher, irrigation solution, osmotic diuretic, dialysis solution. They produce 400-milligram Ciprofloxacin infusion in 200 milliliter with 5% dextose. Apart from the single dose dispensers, the Company launched multi-dose eye/ ear drops in plastic containers. The dispensers are made using the form-fill-seal technology.In September 1994, the Company came out with a Public Issue at a premium of Rs 80, aggregating Rs 7.03 crore, to part-finance their Rs 8.97 Cr. expansion. During the year 1994-95, the Company set up a joint venture unit in Ukraine for manufacture of a wide range of pharmaceuticals. In addition, they... Read More


Reports by Parenteral Drugs (India) Ltd


Reports by Parenteral Drugs (India) Ltd

Company FAQ

No Record Found